Prospective - trials in set-up or submitted for funding


DEBIOC

A Phase I dose-escalating and safety study of AZD8931 in combination with Oxaliplatin and Capecitabine chemotherapy in patients with Oesophago-gastric adenocarcinoma

OCTO banner